[Chronic graft-versus-host disease].
Chuhjo
Tatsuya
T
Division of Internal Medicine, NTT West Kanazawa Hospital.
Shiobara
Shintaro
S
D000818:Animals; D015551:Autoimmunity; D002908:Chronic Disease; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006680:HLA Antigens; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D011701:PUVA Therapy; D036102:Peripheral Blood Stem Cell Transplantation; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D012307:Risk Factors; D012720:Severity of Illness Index; D018418:Th2 Cells / Q000276:immunology; D014019:Tissue Donors
D006680:HLA Antigens; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone